vs

Side-by-side financial comparison of DigitalBridge Group, Inc. (DBRG) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.

DigitalBridge Group, Inc. is the larger business by last-quarter revenue ($105.7M vs $57.3M, roughly 1.8× RHYTHM PHARMACEUTICALS, INC.). DigitalBridge Group, Inc. runs the higher net margin — 61.5% vs -83.0%, a 144.5% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 4.1%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 19.2%).

DigitalBridge Group, Inc. is a global digital infrastructure investment firm. The company owns, invests in and operates businesses such as cell towers, data centers, fiber, small cells, and edge infrastructure. Headquartered in Boca Raton, DigitalBridge has offices in Los Angeles, New York, Denver, London, and Singapore. As of June 2025, DigitalBridge had US$106 billion of assets under management.

Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.

DBRG vs RYTM — Head-to-Head

Bigger by revenue
DBRG
DBRG
1.8× larger
DBRG
$105.7M
$57.3M
RYTM
Growing faster (revenue YoY)
RYTM
RYTM
+32.7% gap
RYTM
36.9%
4.1%
DBRG
Higher net margin
DBRG
DBRG
144.5% more per $
DBRG
61.5%
-83.0%
RYTM
Faster 2-yr revenue CAGR
RYTM
RYTM
Annualised
RYTM
48.5%
19.2%
DBRG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DBRG
DBRG
RYTM
RYTM
Revenue
$105.7M
$57.3M
Net Profit
$65.1M
$-47.5M
Gross Margin
91.6%
Operating Margin
-82.2%
Net Margin
61.5%
-83.0%
Revenue YoY
4.1%
36.9%
Net Profit YoY
-9.6%
EPS (diluted)
$0.28
$-0.73

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DBRG
DBRG
RYTM
RYTM
Q4 25
$105.7M
$57.3M
Q3 25
$93.3M
$51.3M
Q2 25
$85.3M
$48.5M
Q1 25
$90.1M
$32.7M
Q4 24
$101.6M
$41.8M
Q3 24
$76.6M
$33.3M
Q2 24
$390.3M
$29.1M
Q1 24
$74.4M
$26.0M
Net Profit
DBRG
DBRG
RYTM
RYTM
Q4 25
$65.1M
$-47.5M
Q3 25
$31.4M
$-52.9M
Q2 25
$31.6M
$-46.6M
Q1 25
$13.8M
$-49.5M
Q4 24
$-43.3M
Q3 24
$13.8M
$-43.6M
Q2 24
$91.4M
$-32.3M
Q1 24
$-29.6M
$-141.4M
Gross Margin
DBRG
DBRG
RYTM
RYTM
Q4 25
91.6%
Q3 25
89.3%
Q2 25
88.6%
Q1 25
88.8%
Q4 24
90.9%
Q3 24
88.5%
Q2 24
89.9%
Q1 24
89.2%
Operating Margin
DBRG
DBRG
RYTM
RYTM
Q4 25
-82.2%
Q3 25
-13.9%
-102.6%
Q2 25
-31.2%
-93.4%
Q1 25
-11.5%
-143.7%
Q4 24
5.7%
-98.6%
Q3 24
62.4%
-132.0%
Q2 24
33.5%
-139.2%
Q1 24
-20.7%
-538.7%
Net Margin
DBRG
DBRG
RYTM
RYTM
Q4 25
61.5%
-83.0%
Q3 25
33.7%
-103.1%
Q2 25
37.1%
-96.1%
Q1 25
15.3%
-151.4%
Q4 24
-103.6%
Q3 24
18.0%
-131.2%
Q2 24
23.4%
-110.9%
Q1 24
-39.8%
-544.4%
EPS (diluted)
DBRG
DBRG
RYTM
RYTM
Q4 25
$0.28
$-0.73
Q3 25
$0.09
$-0.82
Q2 25
$0.10
$-0.75
Q1 25
$-0.01
$-0.81
Q4 24
$-0.71
Q3 24
$-0.01
$-0.73
Q2 24
$0.44
$-0.55
Q1 24
$-0.28
$-2.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DBRG
DBRG
RYTM
RYTM
Cash + ST InvestmentsLiquidity on hand
$382.5M
$388.9M
Total DebtLower is stronger
$298.8M
Stockholders' EquityBook value
$2.1B
$139.1M
Total Assets
$3.4B
$480.2M
Debt / EquityLower = less leverage
0.14×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DBRG
DBRG
RYTM
RYTM
Q4 25
$382.5M
$388.9M
Q3 25
$358.4M
$416.1M
Q2 25
$340.7M
$291.0M
Q1 25
$349.9M
$314.5M
Q4 24
$302.2M
$320.6M
Q3 24
$294.4M
$298.4M
Q2 24
$261.2M
$319.1M
Q1 24
$247.4M
$201.2M
Total Debt
DBRG
DBRG
RYTM
RYTM
Q4 25
$298.8M
Q3 25
$327.9M
Q2 25
$298.0M
Q1 25
$296.9M
Q4 24
$296.4M
Q3 24
$295.8M
Q2 24
$295.3M
Q1 24
$366.5M
Stockholders' Equity
DBRG
DBRG
RYTM
RYTM
Q4 25
$2.1B
$139.1M
Q3 25
$2.1B
$148.8M
Q2 25
$2.0B
$-11.9M
Q1 25
$2.0B
$18.9M
Q4 24
$2.0B
$21.7M
Q3 24
$2.0B
$11.2M
Q2 24
$2.0B
$39.3M
Q1 24
$1.8B
$61.6M
Total Assets
DBRG
DBRG
RYTM
RYTM
Q4 25
$3.4B
$480.2M
Q3 25
$3.5B
$506.9M
Q2 25
$3.4B
$372.7M
Q1 25
$3.4B
$386.7M
Q4 24
$3.5B
$392.3M
Q3 24
$3.5B
$363.6M
Q2 24
$3.5B
$381.8M
Q1 24
$3.5B
$258.7M
Debt / Equity
DBRG
DBRG
RYTM
RYTM
Q4 25
0.14×
Q3 25
0.16×
Q2 25
0.15×
Q1 25
0.15×
Q4 24
0.15×
Q3 24
0.15×
Q2 24
0.15×
Q1 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DBRG
DBRG
RYTM
RYTM
Operating Cash FlowLast quarter
$259.3M
$-25.4M
Free Cash FlowOCF − Capex
$258.0M
FCF MarginFCF / Revenue
244.0%
Capex IntensityCapex / Revenue
1.3%
Cash ConversionOCF / Net Profit
3.99×
TTM Free Cash FlowTrailing 4 quarters
$440.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DBRG
DBRG
RYTM
RYTM
Q4 25
$259.3M
$-25.4M
Q3 25
$56.5M
$-26.6M
Q2 25
$77.0M
$-23.3M
Q1 25
$50.3M
$-40.4M
Q4 24
$60.1M
$-18.8M
Q3 24
$35.9M
$-25.2M
Q2 24
$22.5M
$-29.1M
Q1 24
$-27.0M
$-40.7M
Free Cash Flow
DBRG
DBRG
RYTM
RYTM
Q4 25
$258.0M
Q3 25
$56.1M
Q2 25
$76.4M
Q1 25
$50.0M
Q4 24
$56.5M
Q3 24
Q2 24
$22.3M
Q1 24
$-30.1M
FCF Margin
DBRG
DBRG
RYTM
RYTM
Q4 25
244.0%
Q3 25
60.2%
Q2 25
89.5%
Q1 25
55.5%
Q4 24
55.7%
Q3 24
Q2 24
5.7%
Q1 24
-40.4%
Capex Intensity
DBRG
DBRG
RYTM
RYTM
Q4 25
1.3%
Q3 25
0.4%
Q2 25
0.7%
Q1 25
0.3%
Q4 24
3.5%
Q3 24
0.0%
Q2 24
0.1%
Q1 24
4.1%
Cash Conversion
DBRG
DBRG
RYTM
RYTM
Q4 25
3.99×
Q3 25
1.80×
Q2 25
2.43×
Q1 25
3.65×
Q4 24
Q3 24
2.61×
Q2 24
0.25×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons